Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer
European Journal of Nuclear Medicine and Molecular Imaging · 2024-10 · 51 (12) · 3731-3743
DOI: 10.1007/s00259-024-06808-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 27.06.2024. Verfasst von Rongxi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and …. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Positron Emission Tomography Computed Tomography, Gastrointestinal Neoplasms, Claudins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, Chinese Academy of Medical Science Innovation Fund for Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Ch…
- Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
- Medical Department of General Surgery, The 1st Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
- Department of General Surgery, The 7th Medical Center, Chinese PLA General Hospital, Beijing, 100700, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
- Medical Department of General Surgery, The 1st Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. dujf66@126.com.
Förderung
- National High Level Hospital Clinical Research Funding
- Chinese Academy of Medical Science Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, R., Bai, Z., Zhong, W., Li, C., Wang, J., Xiang, J., Du, J., Jia, B., & Zhu, Z. (2024). Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer. European Journal of Nuclear Medicine and Molecular Imaging, 51(12), 3731-3743. https://doi.org/10.1007/s00259-024-06808-5
Vancouver
Wang R, Bai Z, Zhong W, Li C, Wang J, Xiang J, et al. Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(12):3731-3743. doi:10.1007/s00259-024-06808-5
BibTeX
@article{Wang2024,
author = {Wang, Rongxi and Bai, Zhidong and Zhong, Wentao and Li, Chenzhen and Wang, Jiarou and Xiang, Jialin and Du, Junfeng and Jia, Bing and Zhu, Zhaohui},
title = {Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
volume = {51},
number = {12},
pages = {3731--3743},
doi = {10.1007/s00259-024-06808-5}
}
EUVIMED